Company overview
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. The company operates in two segments, Surgical Glaucoma and Dry Eye. Its products include OMNI surgical system, an implant-free, handheld, single-use, therapeutic technology that enables ophthalmic surgeons to perform a comprehensive procedure indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, as well as for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and SION surgical instrument, a bladeless manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The company also provides TearCare system, a dry eye device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing SGHT with another company.
| Daily close (USD) | $8.47 |
| Market capitalization (USD) | $466,595,275.3 |
| Price / earnings (TTM) | Not reported |
| Price / book | 8.82 |
No matching rows. Clear the filter to see all records.
Read SGHT's valuation metrics
Company size
Sight Sciences, Inc. Common Stock's recorded market capitalization is $466,595,275.3. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
SGHT's recorded price-to-book ratio is 8.82. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Sight Sciences, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about SGHT. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow SGHT's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.